文献速递主动脉疾病

EVAR 转换开放腹主动脉瘤修复适应证增加且技术复杂度提升但并发症风险下降

Endovascular aneurysm repair conversion is an increasingly common indication for open abdominal aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2021-07-24

单中心回顾分析2002—2019年184例EVAR转换开放腹主动脉瘤修复(EVAR-c),对比两个时期发现EVAR-c占开放修复比例由9%升至27%(P<.001),间隔时间延长、技术复杂度增加,但并发症风险下降(OR 0.88,95%CI .8-.9,P=.01),1年和3年生存相似。

要点

  • EVAR-c占开放腹主动脉瘤修复比例由9%升至27%(P<.001)。
  • EVAR-c距首次EVAR时间延长(中位16个月 vs 48个月,P=.008)。
  • 并发症风险下降(OR 0.88,95%CI .8-.9,P=.01),1年和3年生存相似。

核心结论

  • EVAR-c已成为开放腹主动脉瘤修复的常见适应证。
  • 尽管技术复杂度增加,在高容量主动脉转诊中心管理时并发症风险下降且生存可比。

研究设计与样本

  • 回顾性单中心分析2002—2019年所有开放腹主动脉瘤修复,其中EVAR-c患者184例。
  • 按时期分为2002—2009年(n=21)和2010—2019年(n=163)两组比较,采用逻辑回归和Cox比例风险模型进行风险校正比较。

主要发现

  • EVAR-c占开放修复比例由9%升至27%(P<.001)。
  • EVAR-c患者平均年龄71±9岁,女性比例下降(P=.01),ASA>3比例下降(P=.05)。
  • EVAR-c前再干预时间缩短(中位23个月 vs 0个月,P=.005),至EVAR-c时间延长(中位16个月 vs 48个月,P=.008)。
  • 腹膜后入路(14% vs 77%,P<.0001)、肾上阻断(P=.04)和内脏缺血时间(中位0分钟 vs 5分钟,P=.05)增加,估计失血量(P趋势=.03)和手术时间(P=.008)下降。
  • 择期30天死亡率无统计学差异(10% vs 5%,P=.5),非择期无变化(18% vs 16%,P=.9),并发症风险下降(OR 0.88,95%CI .8-.9,P=.01),1年和3年生存相似。

临床怎么用

  • EVAR-c患者常以非择期方式就诊且距首次EVAR间隔越来越长,需长期随访和再干预规划。
  • 在高容量主动脉转诊中心,尽管技术复杂度增加,EVAR-c仍可预期并发症风险下降和可比生存。

局限性

  • 回顾性单中心设计。
  • 部分亚组样本量小(如2002—2009年仅21例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although endovascular aneurysm repair (EVAR) reintervention is common, conversion to open repair (EVAR-c) occurs less frequently but can be associated with significant technical complexity and perioperative risk. There is a paucity of data highlighting the evolution of periprocedural results surrounding EVAR-c and change in practice patterns, especially for referral centers that increasingly manage EVAR failures. The purpose of this analysis was to perform a temporal analysis of our EVAR-c experience and describe changes in patient selection, operative details, and outcomes. METHODS: A retrospective single-center review of all open abdominal aortic aneurysm repairs was performed (2002-2019), and EVAR-c procedures were subsequently analyzed. EVAR-c patients (n = 184) were categorized into two different eras (2002-2009, n = 21; 2010-2019, n = 163) for comparison. Logistic regression and Cox proportional hazards modeling were used for risk-adjusted comparisons. RESULTS: A significant increase in EVAR-c as an indication for any type of open aneurysm repair was detected (9% to 27%; P < .001). Among EVAR-c patients, no change in age or individual comorbidities was evident (mean age, 71 ± 9 years); however, the proportion of female patients (P = .01) and American Society of Anesthesiologists classification >3 declined (P = .05). There was no difference in prevalence (50% vs 43%; P = .6) or number (median, 1.5 [interquartile range (IQR), 0-5]) of preadmission EVAR reinterventions; however, time to reintervention decreased (median, 23 [IQR, 6-34] months vs 0 [IQR, 0-22] months; P = .005). In contrast, time to EVAR-c significantly increased (median, 16 [IQR, 9-39] months vs 48 [IQR, 20-83] months; P = .008). No difference in frequency of nonelective presentation (mean, 52%; P = .9] or indication was identified, but a trend toward increasing mycotic EVAR-c was observed (5% vs 15%; P = .09). Use of retroperitoneal exposure (14% vs 77%; P < .0001), suprarenal cross-clamp application (6286%; P = .04), and visceral-ischemia time (median, 0 [IQR, 0-11] minutes vs 5 [IQR, 0-20] minutes; P = .05) all increased. In contrast, estimated blood loss (P trend = .03) and procedure time (P = .008) decreased. The unadjusted elective 30-day mortality rate improved but did not reach statistical significance (elective, 10% vs 5%; P = .5) with no change for non-elective operations (18% vs 16%; P = .9). However, a significantly decreased risk of complications was evident (odds ratio, 0.88; 95% confidence interval, .8-.9; P = .01). One- and 3-year survival was similar over time. CONCLUSIONS: EVAR-c is now a common indication for open abdominal aortic aneurysm repair. Patients frequently present nonelectively and at increasingly later intervals after their index EVAR. Despite increasing technical complexity, decreased complication risk and comparable survival can be anticipated when patients are managed at a high-volume aortic referral center.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jacobs CR, Scali ST, Khan T, et al. Endovascular aneurysm repair conversion is an increasingly common indication for open abdominal aortic aneurysm repair. J Vasc Surg. 2021. PMID: 34314833. doi:10.1016/j.jvs.2021.07.121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。